CLDN5 and glioblastoma: A single-cell transcriptomics study of GBM patients revealed altered expression of CLDN5, c1qRs, and C5 in brain cells, with CLDN5 predominantly expressed in malignant GBM cells and C1QL1 an early diagnostic marker for GBM.